Puma Biotechnology, Inc. (PBYI)
7.115
+0.02
(+0.21%)
USD |
NASDAQ |
Feb 04, 16:00
6.95
-0.16
(-2.32%)
After-Hours: 20:00
Puma Biotechnology Market Cap : 358.53M for Feb. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nephros, Inc. | 44.10M |
| ACADIA Pharmaceuticals, Inc. | 4.099B |
| Vanda Pharmaceuticals, Inc. | 448.25M |
| CorMedix, Inc. | 618.10M |
| Relmada Therapeutics, Inc. | 268.40M |
Market Cap Related Metrics
| PE Ratio | 9.606 |
| PS Ratio | 1.681 |
| PEG Ratio | 0.1717 |
| Price to Book Value | 3.110 |
| Price to Free Cash Flow | 8.315 |
| Price | 7.115 |
| Earnings Yield | 10.41% |
| PEGY Ratio | 0.1717 |
| Operating PE Ratio | 10.62 |
| Normalized PE Ratio | 9.606 |